Late Preterm Steroids: No Lung Benefit - Takeaways - MDSpire
From the Journals

Late Preterm Steroids: No Lung Benefit

Follow-up of the ALPS trial found similar rates of respiratory impairment at age 6 years or older with betamethasone vs placebo

  • By

  • Andrea Surnit

  • May 12, 2026

  • 5 min

Share

  • 1

    The study followed up on children exposed to antenatal betamethasone.

  • 2

    No significant difference in respiratory impairment rates between betamethasone and placebo groups.

  • 3

    Study included 1,218 pediatric patients aged 6 or older.

  • 4

    Respiratory outcomes assessed via spirometry and caregiver questionnaires.

  • 5

    Findings did not support long-term pulmonary benefits of betamethasone.

  • 6

    Enrollment challenges were noted due to the COVID-19 pandemic.

  • 7

    Study advises adherence to current guidelines for antenatal corticosteroid use.

Original Source(s)

Late Preterm Steroids: No Lung Benefit

  • by Andrea Surnit

  • May 12, 2026

Related Content

PCOS Renamed PMOS After Global Consensus

International initiative reframes a common endocrine disorder around its metabolic and ovarian features rather than ovarian cysts

HPV Vaccine Uptake Varied Widely Across US States

Analysis of more than 16,000 US adolescents found substantial variation in HPV vaccination uptake both across and within census regions

Robotic Surgery Shows Early Promise in Gynecology

Small retrospective studies suggest perioperative feasibility, but comparative and fertility data remain limited